Search clinical trials for: First generation BuTrans patch

Total 78 results

Mundipharma Research Limited

Completed

A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches

Pain

United Kingdom
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers

Smoking

United States
Purdue Pharma LP
Napp Pharmaceuticals Limited

Completed

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

Chronic Non-malignant Pain

United States, United Kingdom
Beijing Chaoyang District Centre for Disease Control...

Unknown

Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months

Hand Foot and Mouth Disease
Abbott Medical Devices

Completed

Non-vascular ICD Electrode Configuration Feasibility Study

Ventricular Arrythmia

Chile, Czechia, Paraguay
Assiut University

Unknown

Comparison of Mid-term Results of Total Correction of TOF Between Preservation of PV and Trans-annular Patch.

Tetrology of Fallot
Purdue Pharma LP

Terminated

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

Osteoarthritis

United States
Tian Xie
LinkDoc Technology (Beijing) Co. Ltd.

Recruiting

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study (SELECT-2)

Adenocarcinoma | Carcinoma | Non-Small-Cell Lung Cancer

China
Montreal Heart Institute

Enrolling by invitation

Genetic Risk-Based Atrial Fibrillation Screening (GeneAF Study) (GeneAF)

Atrial Fibrillation | Genetic Predisposition

Canada
Centre Hospitalier Universitaire Saint Pierre

Terminated

EBUS-Miniprobes Sampling for Peripheral Lung Lesions

Lung Cancer | Peripheral Pulmonary Lesions

Belgium
Purdue Pharma LP

Completed

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Chronic Nonmalignant Pain

United States
Purdue Pharma LP

Completed

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Healthy

United States
Purdue Pharma LP

Terminated

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Osteoarthritis

United States
Purdue Pharma LP

Terminated

Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase

Osteoarthritis

United States
Purdue Pharma LP

Terminated

Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

Back Pain Lower Back Chronic

United States
Jiangsu Province Centers for Disease Control and...
Wuhan Institute of Biological Products Co., Ltd

Completed

Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China

Hand, Foot and Mouth Disease

China
Purdue Pharma LP

Completed

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Osteoarthritis

United States
Purdue Pharma LP

Terminated

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Postoperative Pain

United States
Daping Hospital and the Research Institute of Surgery...

Unknown

Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE

Esophageal Neoplasms | Esophagectomy

China
EndoStim Inc.

Terminated

An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux

Gastroesophageal Reflux | Reflux, Gastroesophageal | Gastroesophageal Reflux Disease (GERD) | Acid Reflux

United States, Belgium, Netherlands, United Kingdom
Command Hospital, India

Unknown

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Chronic Myeloid Leukemia | Treatment Free Remission

India
Gilead Sciences

Recruiting

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)

Ulcerative Colitis

United States
Purdue Pharma LP

Completed

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Osteoarthritis

United States
Centre hospitalier de l'Université de Montréal...
University Hospital, Brest

Completed

Stenting in the Treatment of Aneurysm Trial (STAT)

Intracranial Aneurysm

Canada, France
Rigshospitalet, Denmark

Completed

Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

Diabetes Mellitus | Pregnancy Complications

Denmark
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Netherlands, Canada, Hungary, Moldova, Republic of, Romania
Chen Qian

Recruiting

Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents

Depression

China
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. (BP96-0604)

Back Pain

United States
GlaxoSmithKline

Completed

Bupropion and Specific Cardiovascular Malformations

Depressive Disorder | Smoking Cessation | Pregnancy
Purdue Pharma LP

Completed

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole

Healthy

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

Healthy Volunteers

United States
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Foundation; Rutgers Cancer Institute of New Jersey

Completed

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Smoking Cessation

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Smoking Cessation Intervention: Effectiveness in Primary Care

Tobacco Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Impact of Smoking Cessation on Sleep - 5

Tobacco Use Cessation | Sleep Disorders

United States
North Suffolk Mental Health Association

Completed

Smoking Relapse Prevention in Schizophrenia

Schizophrenia | Schizoaffective Disorder | Smokers

United States
Southern Illinois University Carbondale
National Institute on Drug Abuse (NIDA)

Completed

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Nicotine Dependence

United States
US Department of Veterans Affairs

Completed

Non-Nicotine Agents for Smoking Cessation

Tobacco Use Disorder

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms

Nicotine Dependence

United States
GlaxoSmithKline

Completed

Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic

Depressive Disorder and Anxiety Disorders

United Kingdom
Aalborg University

Unknown

Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol

Pain | Neuropathic Pain | Pruritus | Dermatology/Skin - Other

Denmark
Mark Vander Weg
VA Office of Research and Development

Unknown

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Tobacco Use | Nicotine Dependence

United States
Chinese PLA General Hospital

Unknown

Study on the Model of Smoking Cessation Intervention and Service Ability Improvement

Smoking Cessation
GlaxoSmithKline

Completed

Bupropion & Cardio Birth Defect (Slone)

Depressive Disorder
Iowa City Veterans Affairs Medical Center
US Department of Veterans Affairs

Completed

Tailored Tobacco Quitline for Rural Veterans

Cigarette Smoking

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Tobacco Use Disorder | Tobacco Use Cessation

United States
University of Tennessee
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

Schizophrenia | Tobacco Use Disorder | Tobacco Use Cessation
North Suffolk Mental Health Association

Completed

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Citalopram in Treating Postmenopausal Women With Hot Flashes

Breast Cancer | Hot Flashes | Psychosocial Effects of Cancer and Its Treatment

United States

Search clinical trials for: First generation BuTrans patch

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations